HALB (Halberd) EBITDA Margin %: -14,866.67% (As of Jul. 2023)


What is Halberd EBITDA Margin %?

Halberd HALB EBITDA Margin % is -14,866.67% as of Jul. 2023.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Halberd's EBITDA for the six months ended in Jul. 2023 was $-0.45 Mil. Halberd's Revenue for the six months ended in Jul. 2023 was $0.00 Mil. Therefore, Halberd's EBITDA margin for the quarter that ended in Jul. 2023 was -14,866.67%.

Halberd  (OTCPK:HALB) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Halberd EBITDA Margin % Related Terms

Halberd EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Halberd's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Halberd EBITDA Margin % Chart

Halberd Annual Data
Trend Jul08 Jul22 Jul23
EBITDA Margin %
-500.00 -20,225.00 -14,866.67

Halberd Semi-Annual Data
Jul08 Jul22 Jul23
EBITDA Margin % -500.00 -20,225.00 -14,866.67

HALB vs GRI, OCEA, PCSA: EBITDA Margin % Comparison

For the Biotechnology subindustry, Halberd's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Halberd EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Halberd's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Halberd's EBITDA Margin % falls into.


Halberd EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Halberd's EBITDA Margin % for the fiscal year that ended in Jul. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Jul. 2023 )/Revenue (A: Jul. 2023 )
=-0.446/0.003
=-14,866.67 %

Halberd's EBITDA Margin % for the quarter that ended in Jul. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Jul. 2023 )/Revenue (Q: Jul. 2023 )
=-0.446/0.003
=-14,866.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -14,866.67% mean?
Halberd (HALB) has a EBITDA Margin % of -14,866.67% as of Jul. 2023. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Halberd and its competitors.
Is Halberd's EBITDA Margin % too high?
Halberd's current EBITDA Margin % is -14,866.67%.
How does Halberd's EBITDA Margin % compare to GRI and OCEA?
Halberd's EBITDA Margin % of -14,866.67% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Halberd and its competitors. Halberd's current EBITDA Margin % is -14,866.67%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Halberd stock overvalued right now?
Halberd (HALB) has a current EBITDA Margin % of -14,866.67%. The current EBITDA Margin % is -14,866.67%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Halberd (HALB), the current EBITDA Margin % is -14,866.67% as of Jul. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Halberd Business Description

Address P.O. Box 25, Jackson Center, PA, USA, 16133
Halberd Corp is a holding company and acquisition vehicle for established businesses. It is also developing a patented process for disease eradication by removing the pathophysiologic basis of the disease. The company is focused on developing treatments for neurodegenerative diseases, such as PTSD and CTE (Post Traumatic Stress Disorder and Chronic Traumatic Encephalopathy), Alzheimer's Disease, Parkinson's Disease, etc.